234 related articles for article (PubMed ID: 30586414)
21. Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer.
Sakuma M; Akahira J; Suzuki T; Inoue S; Ito K; Moriya T; Sasano H; Okamura K; Yaegashi N
Gynecol Oncol; 2005 Dec; 99(3):664-70. PubMed ID: 16140366
[TBL] [Abstract][Full Text] [Related]
22. Promoter analysis of mouse estrogen-responsive finger protein (efp) gene: mouse efp promoter contains an E-box that is also conserved in human.
Ikeda K; Inoue S; Orimo A; Tsutsumi K; Muramatsu M
Gene; 1998 Aug; 216(1):155-62. PubMed ID: 9714786
[TBL] [Abstract][Full Text] [Related]
23. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase.
Zou W; Zhang DE
J Biol Chem; 2006 Feb; 281(7):3989-94. PubMed ID: 16352599
[TBL] [Abstract][Full Text] [Related]
24. Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha.
Orimo A; Inoue S; Minowa O; Tominaga N; Tomioka Y; Sato M; Kuno J; Hiroi H; Shimizu Y; Suzuki M; Noda T; Muramatsu M
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12027-32. PubMed ID: 10518570
[TBL] [Abstract][Full Text] [Related]
25. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
26. Molecular cloning of rat efp: expression and regulation in primary osteoblasts.
Inoue S; Urano T; Ogawa S; Saito T; Orimo A; Hosoi T; Ouchi Y; Muramatsu M
Biochem Biophys Res Commun; 1999 Aug; 261(2):412-8. PubMed ID: 10425199
[TBL] [Abstract][Full Text] [Related]
27. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
28. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.
Zhang L; Zhang B; Wei M; Xu Z; Kong W; Deng K; Xu X; Zhang L; Ζhao X; Yan L
Int J Oncol; 2020 May; 56(5):1225-1239. PubMed ID: 32319602
[TBL] [Abstract][Full Text] [Related]
29. A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/β-catenin signaling pathway in breast cancer.
Li K; Pan W; Ma Y; Xu X; Gao Y; He Y; Wei L; Zhang J
Pathol Res Pract; 2019 Oct; 215(10):152573. PubMed ID: 31399258
[TBL] [Abstract][Full Text] [Related]
30. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
[TBL] [Abstract][Full Text] [Related]
31. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
[TBL] [Abstract][Full Text] [Related]
32. An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cells.
Sun PM; Gao M; Wei LH; Mustea A; Wang JL; Könsgen D; Lichtenegger W; Sehouli J
Int J Gynecol Cancer; 2006; 16 Suppl 2():564-8. PubMed ID: 17010074
[TBL] [Abstract][Full Text] [Related]
33. Tripartite motif-containing protein 6 facilitates growth and migration of breast cancer through degradation of STUB1.
Wei C; Wu J; Liu W; Lu J; Li H; Hai B
Eur J Histochem; 2021 Mar; 65(1):. PubMed ID: 33728863
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells.
Treeck O; Diepolder E; Skrzypczak M; Schüler-Toprak S; Ortmann O
BMC Cancer; 2019 Jul; 19(1):745. PubMed ID: 31357971
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
Qin Y; Cui H; Zhang H
Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
[TBL] [Abstract][Full Text] [Related]
36. TRIM9 overexpression promotes uterine leiomyoma cell proliferation and inhibits cell apoptosis via NF-κB signaling pathway.
Yang F; Liu H; Yu Y; Xu L
Life Sci; 2020 Sep; 257():118101. PubMed ID: 32679146
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs.
Orimo A; Inoue S; Ikeda K; Noji S; Muramatsu M
J Biol Chem; 1995 Oct; 270(41):24406-13. PubMed ID: 7592654
[TBL] [Abstract][Full Text] [Related]
39. Uterine preparation for implantation in the mouse is associated with coordinate expression of estrogen-responsive finger protein and estrogen receptor.
Das N; Wang J; Dey SK
Mol Reprod Dev; 1997 Apr; 46(4):499-506. PubMed ID: 9094097
[TBL] [Abstract][Full Text] [Related]
40. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]